The computational anatomy of psychosis
Rick A Adams, Klaas Enno Stephan, Harriet R Brown, Christopher D Frith, Karl J Friston, Rick A Adams, Klaas Enno Stephan, Harriet R Brown, Christopher D Frith, Karl J Friston
Abstract
This paper considers psychotic symptoms in terms of false inferences or beliefs. It is based on the notion that the brain is an inference machine that actively constructs hypotheses to explain or predict its sensations. This perspective provides a normative (Bayes-optimal) account of action and perception that emphasizes probabilistic representations; in particular, the confidence or precision of beliefs about the world. We will consider hallucinosis, abnormal eye movements, sensory attenuation deficits, catatonia, and delusions as various expressions of the same core pathology: namely, an aberrant encoding of precision. From a cognitive perspective, this represents a pernicious failure of metacognition (beliefs about beliefs) that can confound perceptual inference. In the embodied setting of active (Bayesian) inference, it can lead to behaviors that are paradoxically more accurate than Bayes-optimal behavior. Crucially, this normative account is accompanied by a neuronally plausible process theory based upon hierarchical predictive coding. In predictive coding, precision is thought to be encoded by the post-synaptic gain of neurons reporting prediction error. This suggests that both pervasive trait abnormalities and florid failures of inference in the psychotic state can be linked to factors controlling post-synaptic gain - such as NMDA receptor function and (dopaminergic) neuromodulation. We illustrate these points using biologically plausible simulations of perceptual synthesis, smooth pursuit eye movements and attribution of agency - that all use the same predictive coding scheme and pathology: namely, a reduction in the precision of prior beliefs, relative to sensory evidence.
Keywords: active inference; free energy; illusions; precision; psychosis; schizophrenia; sensory attenuation.
Figures
References
- Abi-Saab W. M., D’Souza D. C., Moghaddam B., Krystal J. H. (1998). The NMDA antagonist model for schizophrenia: promise and pitfalls. Pharmacopsychiatry 31 (Suppl. 2), 104–10910.1055/s-2007-979354
- Adams R. A., Perrinet L. U., Friston K. (2012). Smooth pursuit and visual occlusion: active inference and oculomotor control in schizophrenia. PLoS ONE 7:e47502.10.1371/journal.pone.0047502
- Adams R. A., Shipp S., Friston K. J. (2013). Predictions not commands: active inference in the motor system. Brain Struct. Funct. 218, 611–64310.1007/s00429-012-0475-5
- Albrecht M. A., Martin-Iverson M. T., Price G., Lee J., Iyyalol R., Waters F. (2011). Dexamphetamine effects on separate constructs in the rubber hand illusion test. Psychopharmacology (Berl.) 217, 39–5010.1007/s00213-011-2255-y
- Allen P., Aleman A., McGuire P. K. (2007). Inner speech models of auditory verbal hallucinations: evidence from behavioural and neuroimaging studies. Int. Rev. Psychiatry 19, 407–41510.1080/09540260701486498
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, 4th Edn Washington, DC: American Psychiatric Association
- Arnold S. E., Hyman B. T., Van Hoesen G. W., Damasio A. R. (1991). Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Arch. Gen. Psychiatry 48, 625–63210.1001/archpsyc.1991.01810310043008
- Bagal A. A., Kao J. P. Y., Tang C.-M., Thompson S. M. (2005). Long-term potentiation of exogenous glutamate responses at single dendritic spines. Proc. Natl. Acad. Sci. U.S.A. 102, 14434–1443910.1073/pnas.0501956102
- Ballard D. H., Hinton G. E., Sejnowski T. J. (1983). Parallel visual computation. Nature 306, 21–2610.1038/306021a0
- Bastos A. M., Usrey W. M., Adams R. A., Mangun G. R., Fries P., Friston K. J. (2012). Canonical microcircuits for predictive coding. Neuron 76, 695–71110.1016/j.neuron.2012.10.038
- Benes F. M., McSparren J., Bird E. D., SanGiovanni J. P., Vincent S. L. (1991). Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48, 996–100110.1001/archpsyc.1991.01810350036005
- Black J. E., Kodish I. M., Grossman A. W., Klintsova A. Y., Orlovskaya D., Vostrikov V., et al. (2004). Pathology of layer V pyramidal neurons in the prefrontal cortex of patients with schizophrenia. Am. J. Psychiatry 161, 742–74410.1176/appi.ajp.161.4.742
- Blakemore S. J., Wolpert D. M., Frith C. D. (1998). Central cancellation of self-produced tickle sensation. Nat. Neurosci. 1, 635–64010.1038/2870
- Breier A., Su T. P., Saunders R., Carson R. E., Kolachana B. S., de Bartolomeis A., et al. (1997). Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc. Natl. Acad. Sci. U.S.A. 94, 2569–257410.1073/pnas.94.6.2569
- Brodersen K. H., Schofield T. M., Leff A. P., Ong C. S., Lomakina E. I., Buhmann J. M., et al. (2011). Generative embedding for model-based classification of fMRI data. PLoS Comput. Biol. 7:e1002079.10.1371/journal.pcbi.1002079
- Brown H., Adams R. A., Parees I., Edwards M., Friston K. (in press). Active inference, sensory attenuation and illusions. Cogn. Process.
- Calkins M. E., Iacono W. G., Ones D. S. (2008). Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes. Brain Cogn. 68, 436–46110.1016/j.bandc.2008.09.001
- Campion D., Thibaut F., Denise P., Courtin P., Pottier M., Levillain D. (1992). SPEM impairment in drug-naive schizophrenic patients: evidence for a trait marker. Biol. Psychiatry 32, 891–90210.1016/0006-3223(92)90178-3
- Cardoso-Leite P., Mamassian P., Schütz-Bosbach S., Waszak F. (2010). A new look at sensory attenuation. Action-effect anticipation affects sensitivity, not response bias. Psychol. Sci. 21, 1740–174510.1177/0956797610389187
- Carlsson A., Waters N., Carlsson M. L. (1999). Neurotransmitter interactions in schizophrenia-therapeutic implications. Eur. Arch. Psychiatry Clin. Neurosci. 249 (Suppl. 4), 37–4310.1007/PL00014183
- Cepeda C., Levine M. S. (2006). Where do you think you are going? The NMDA-D1 receptor trap. Sci. STKE 2006, e20
- Chawla D., Lumer E. D., Friston K. J. (1999). The relationship between synchronization among neuronal populations and their mean activity levels. Neural Comput. 11, 1389–141110.1162/089976699300016287
- Corlett P. R., Honey G. D., Krystal J. H., Fletcher P. C. (2011). Glutamatergic model psychoses: prediction error, learning, and inference. Neuropsychopharmacology 36, 294–31510.1038/npp.2010.163
- Crow T. J. (1980). Molecular pathology of schizophrenia: more than one disease process? Br. Med. J. 280, 66–6810.1136/bmj.280.6207.66
- Dayan P., Hinton G. E., Neal R. M., Zemel R. S. (1995). The Helmholtz machine. Neural Comput. 7, 889–90410.1162/neco.1995.7.5.889
- Dazzan P., Morgan K. D., Chitnis X., Suckling J., Morgan C., Fearon P., et al. (2006). The structural brain correlates of neurological soft signs in healthy individuals. Cereb. Cortex 16, 1225–123110.1093/cercor/bhj063
- De Pasquale R., Sherman S. M. (2012). Modulatory effects of metabotropic glutamate receptors on local cortical circuits. J. Neurosci. 32, 7364–737210.1523/JNEUROSCI.0090-12.2012
- Demjaha A., Murray R. M., McGuire P. K., Kapur S., Howes O. D. (2012). Dopamine synthesis capacity in patients with treatment-resistant schizophrenia. Am. J. Psychiatry 169, 1203–121010.1176/appi.ajp.2012.12010144
- Dima D., Dietrich D. E., Dillo W., Emrich H. M. (2010). Impaired top-down processes in schizophrenia: a DCM study of ERPs. Neuroimage 52, 824–83210.1016/j.neuroimage.2009.12.086
- Dima D., Roiser J. P., Dietrich D. E., Bonnemann C., Lanfermann H., Emrich H. M., et al. (2009). Understanding why patients with schizophrenia do not perceive the hollow-mask illusion using dynamic causal modelling. Neuroimage 46, 1180–118610.1016/j
- Durstewitz D. (2009). Implications of synaptic biophysics for recurrent network dynamics and active memory. Neural Netw. 22, 1189–120010.1016/j.neunet.2009.07.016
- Falkai P., Schneider-Axmann T., Honer W. G. (2000). Entorhinal cortex pre-alpha cell clusters in schizophrenia: quantitative evidence of a developmental abnormality. Biol. Psychiatry 47, 937–94310.1016/S0006-3223(99)00250-4
- Fanous A., Gardner C., Walsh D., Kendler K. S. (2001). Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in non-psychotic relatives. Arch. Gen. Psychiatry 58, 669–67310.1001/archpsyc.58.7.669
- Feldman A. G., Levin M. F. (1995). The origin and use of positional frames of reference in motor control. Behav. Brain Sci. 18, 723–74410.1017/S0140525X0004070X
- Feldman H., Friston K. J. (2010). Attention, uncertainty, and free-energy. Front. Hum. Neurosci. 4:21510.3389/fnhum.2010.00215
- Felleman D. J., Van Essen D. C. (1991). Distributed hierarchical processing in the primate cerebral cortex. Cereb. Cortex 1, 1–4710.1093/cercor/1.1.1
- Fleming S. M., Dolan R. J., Frith C. D. (2012). Metacognition: computation, biology and function. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 1280–128610.1098/rstb.2012.0021
- Fletcher P. C., Frith C. D. (2009). Perceiving is believing: a Bayesian approach to explaining the positive symptoms of schizophrenia. Nat. Rev. Neurosci. 10, 48–5810.1038/nrn2536
- Frank M. J. (2005). Dynamic dopamine modulation in the basal ganglia: a neurocomputational account of cognitive deficits in medicated and non-medicated Parkinsonism. J. Cogn. Neurosci. 17, 51–7210.1162/0898929052880093
- Freeman T. P., Morgan C. J. A., Pepper F., Howes O. D., Stone J. M., Curran H. V. (2013). Associative blocking to reward-predicting cues is attenuated in ketamine users but can be modulated by images associated with drug use. Psychopharmacology (Berl.) 225, 41–5010.1007/s00213-012-2791-0
- Friston K. (2008). Hierarchical models in the brain. PLoS Comput. Biol. 4:e1000211.10.1371/journal.pcbi.1000211
- Friston K. (2009). The free-energy principle: a rough guide to the brain? Trends Cogn. Sci. (Regul. Ed.) 13, 293–30110.1016/j.tics.2009.04.005
- Friston K., Kiebel S. (2009a). Cortical circuits for perceptual inference. Neural Netw. 22, 1093–110410.1016/j.neunet.2009.07.023
- Friston K., Kiebel S. (2009b). Predictive coding under the free-energy principle. Philos. Trans. R. Soc. Lond. B Biol. Sci. 364, 1211–122110.1098/rstb.2008.0300
- Friston K. J. (2005). Hallucinations and perceptual inference. Behav. Brain Sci. 28, 764–76610.1017/S0140525X05290131
- Friston K. J., Daunizeau J., Kiebel S. J. (2009). Reinforcement learning or active inference? PLoS ONE 4:e6421.10.1371/journal.pone.0006421
- Friston K. J., Daunizeau J., Kilner J., Kiebel S. J. (2010a). Action and behavior: a free-energy formulation. Biol. Cybern. 102, 227–26010.1007/s00422-010-0364-z
- Friston K., Stephan K., Li B., Daunizeau J. (2010b). Generalised filtering. Math. Probl. Eng. 2010, 1–3510.1155/2010/621670
- Friston K. J., Harrison L., Penny W. (2003). Dynamic causal modelling. Neuroimage 19, 1273–130210.1016/S1053-8119(03)00202-7
- Friston K. J., Shiner T., Fitzgerald T., Galea J. M., Adams R., Brown H., et al. (2012). Dopamine, affordance and active inference. PLoS Comput. Biol. 8:e1002327.10.1371/journal.pcbi.1002327
- Frith C., Rees G., Friston K. (1998). Psychosis and the experience of self. Brain systems underlying self-monitoring. Ann. N. Y. Acad. Sci. 843, 170–17810.1111/j.1749-6632.1998.tb08213.x
- Frith C. D., Friston K. J. (2012). “False perceptions and false beliefs: understanding schizophrenia,” in Working Group on Neurosciences and the Human Person: New Perspectives on Human Activities, The Pontifical academy of Sciences, 8–10 November 2012, Casina Pio IV
- Fusar-Poli P., Howes O. D., Allen P., Broome M., Valli I., Asselin M.-C., et al. (2011). Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis. Mol. Psychiatry 16, 67–7510.1038/mp.2009.108
- Garety P. A., Freeman D. (1999). Cognitive approaches to delusions: a critical review of theories and evidence. Br. J. Clin. Psychol. 38 (pt. 2), 113–15410.1348/014466599162700
- Ginzburg V. L. (1955). On the theory of superconductivity. Nuovo Cimento C 2, 1234–125010.1007/BF02731579
- Giovanoli S., Engler H., Engler A., Richetto J., Voget M., Willi R., et al. (2013). Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 339, 1095–109910.1126/science.1228261
- Glantz L. A., Lewis D. A. (1997). Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch. Gen. Psychiatry 54, 660–66910.1001/archpsyc.1997.01830190088009
- Glantz L. A., Lewis D. A. (2000). Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 57, 65–7310.1001/archpsyc.57.1.65
- Goff D. C., Coyle J. T. (2001). The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry 158, 1367–137710.1176/appi.ajp.158.9.1367
- Goldman-Rakic P. S., Castner S. A., Svensson T. H., Siever L. J., Williams G. V. (2004). Targeting the dopamine D1 receptor in schizophrenia: insights for cognitive dysfunction. Psychopharmacology (Berl.) 174, 3–1610.1007/s00213-004-1793-y
- Gonzalez-Burgos G., Lewis D. A. (2012). NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr. Bull. 38, 950–95710.1093/schbul/sbs010
- Gray J. A., Feldon J., Rawlins J. N. P., Hemsley D. R., Smith A. D. (1991). The neuropsychology of schizophrenia. Behav. Brain Sci. 14, 1–2010.1017/S0140525X00065055
- Greenwood T. A., Light G. A., Swerdlow N. R., Radant A. D., Braff D. L. (2012). Association analysis of 94 candidate genes and schizophrenia-related endophenotypes. PLoS ONE 7:e29630.10.1371/journal.pone.0029630
- Gunduz-Bruce H., Reinhart R. M. G., Roach B. J., Gueorguieva R., Oliver S., D’Souza D. C., et al. (2012). Glutamatergic modulation of auditory information processing in the human brain. Biol. Psychiatry 71, 969–97710.1016/j.biopsych.2011.09.031
- Haken H. (1983). Synergetics: Introduction and Advanced Topics, 3rd Edn. Berlin: Springer
- Hall J., Romaniuk L., McIntosh A. M., Steele J. D., Johnstone E. C., Lawrie S. M. (2009). Associative learning and the genetics of schizophrenia. Trends Neurosci. 32, 359–36510.1016/j.tins.2009.01.011
- Harrison P. J., Lewis D. A., Kleinman J. E. (2011). “Neuropathology of schizophrenia,” in Schizophrenia, eds Weinberger D. R., Harrison P. J. (Oxford: Wiley-Blackwell; ), 372–392
- Harrison P. J., Weinberger D. R. (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 10, 40–68; image 5.10.1038/sj.mp.4001630
- Hinton G. E., van Camp D. (1993). “Keeping the neural networks simple by minimizing the description length of the weights,” in Proceedings of the Sixth Annual Conference on Computational Learning Theory COLT ’93 (New York, NY: ACM; ), 5–13 Available at: [accessed November 22, 2012]
- Hong L. E., Avila M. T., Thaker G. K. (2005). Response to unexpected target changes during sustained visual tracking in schizophrenic patients. Exp. Brain Res. 165, 125–13110.1007/s00221-005-2276-z
- Howes O. D., Kapur S. (2009). The dopamine hypothesis of schizophrenia: version III – the final common pathway. Schizophr. Bull. 35, 549–56210.1093/schbul/sbp006
- Hutton S. B., Crawford T. J., Gibbins H., Cuthbert I., Barnes T. R., Kennard C., et al. (2001). Short and long term effects of antipsychotic medication on smooth pursuit eye tracking in schizophrenia. Psychopharmacology (Berl.) 157, 284–29110.1007/s002130100803
- Hutton S. B., Crawford T. J., Puri B. K., Duncan L. J., Chapman M., Kennard C., et al. (1998). Smooth pursuit and saccadic abnormalities in first-episode schizophrenia. Psychol. Med. 28, 685–69210.1017/S0033291798006722
- Huys Q. J. M., Dayan P. (2009). A Bayesian formulation of behavioral control. Cognition 113, 314–32810.1016/j.cognition.2009.01.008
- Jabben N., Arts B., van Os J., Krabbendam L. (2010). Neurocognitive functioning as intermediary phenotype and predictor of psychosocial functioning across the psychosis continuum: studies in schizophrenia and bipolar disorder. J. Clin. Psychiatry 71, 764–77410.4088/JCP.08m04837yel
- Jakob H., Beckmann H. (1986). Prenatal developmental disturbances in the limbic allocortex in schizophrenics. J. Neural Transm. 65, 303–32610.1007/BF01249090
- Jansen K. L., Faull R. L., Dragunow M. (1989). Excitatory amino acid receptors in the human cerebral cortex: a quantitative autoradiographic study comparing the distributions of [3H]TCP, [3H]glycine, L-[3H]glutamate, [3H]AMPA and [3H]kainic acid binding sites. Neuroscience 32, 587–60710.1016/0306-4522(89)90282-0
- Johnstone E. C., Owens D. G., Frith C. D., Crow T. J. (1987). The relative stability of positive and negative features in chronic schizophrenia. Br. J. Psychiatry 150, 60–6410.1192/bjp.150.1.60
- Kalus P., Müller T. J., Zuschratter W., Senitz D. (2000). The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport 11, 3621–362510.1097/00001756-200011090-00044
- Kantrowitz J. T., Javitt D. C. (2010). N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res. Bull. 83, 108–12110.1016/j.brainresbull
- Kapur S. (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. Am. J. Psychiatry 160, 13–2310.1176/appi.ajp.160.1.13
- Keane B. P., Silverstein S. M., Wang Y., Papathomas T. V. (in press). Reduced depth inversion illusions in schizophrenia are state specific and occur for multiple object types and viewing conditions. J. Abnorm. Psychol.
- Kessler R. M., Woodward N. D., Riccardi P., Li R., Ansari M. S., Anderson S., et al. (2009). Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects. Biol. Psychiatry 65, 1024–103110.1016/j.biopsych.2008.12.029
- Kiebel S. J., Daunizeau J., Friston K. J. (2009). Perception and hierarchical dynamics. Front. Neuroinform. 3:2010.3389/neuro.11.020.2009
- Kolluri N., Sun Z., Sampson A. R., Lewis D. A. (2005). Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am. J. Psychiatry 162, 1200–120210.1176/appi.ajp.162.6.1200
- Krystal J. H., Karper L. P., Seibyl J. P., Freeman G. K., Delaney R., Bremner J. D., et al. (1994). Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch. Gen. Psychiatry 51, 199–21410.1001/archpsyc.1994.03950030035004
- Laje R., Gardner T. J., Mindlin G. B. (2002). Neuromuscular control of vocalizations in birdsong: a model. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 65, 051921.10.1103/PhysRevE.65.051921
- Laje R., Mindlin G. B. (2002). Diversity within a birdsong. Phys. Rev. Lett. 89, 288102.10.1103/PhysRevLett.89.288102
- Laruelle M., Abi-Dargham A., van Dyck C. H., Gil R., D’Souza C. D., Erdos J., et al. (1996). Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc. Natl. Acad. Sci. U.S.A. 93, 9235–924010.1073/pnas.93.17.9235
- Leung S., Croft R. J., Baldeweg T., Nathan P. J. (2007). Acute dopamine D(1) and D(2) receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects. Psychopharmacology (Berl.) 194, 443–45110.1007/s00213-007-0865-1
- Lewis D. A., Cruz D. A., Melchitzky D. S., Pierri J. N. (2001). Lamina-specific deficits in parvalbumin-immunoreactive varicosities in the prefrontal cortex of subjects with schizophrenia: evidence for fewer projections from the thalamus. Am. J. Psychiatry 158, 1411–142210.1176/appi.ajp.158.9.1411
- Liddle P. F. (1987). The symptoms of chronic schizophrenia. A re-examination of the positive-negative dichotomy. Br. J. Psychiatry 151, 145–15110.1192/bjp.151.2.145
- Lidow M. S., Goldman-Rakic P. S., Gallager D. W., Rakic P. (1991). Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390. Neuroscience 40, 657–67110.1016/0306-4522(91)90003-7
- Lisman J. E., Coyle J. T., Green R. W., Javitt D. C., Benes F. M., Heckers S., et al. (2008). Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 31, 234–24210.1016/j.tins.2008.02.005
- Lochner J. P. A., Burger J. F. (1961). Form of the Loudness function in the presence of masking noise. J. Acoust. Soc. Am. 33, 1705–170710.1121/1.1908548
- Luthringer R., Rinaudo G., Toussaint M., Bailey P., Muller G., Muzet A., et al. (1999). Electroencephalographic characterization of brain dopaminergic stimulation by apomorphine in healthy volunteers. Neuropsychobiology 39, 49–5610.1159/000026560
- Maher B. A. (1974). Delusional thinking and perceptual disorder. J. Individ. Psychol. 30, 98–113
- Mockler D., Riordan J., Sharma T. (1997). Memory and intellectual deficits do not decline with age in schizophrenia. Schizophr. Res. 26, 1–710.1016/S0920-9964(97)00031-5
- Monfils M.-H., Teskey G. C. (2004). Induction of long-term depression is associated with decreased dendritic length and spine density in layers III and V of sensorimotor neocortex. Synapse 53, 114–12110.1002/syn.20039
- Montgomery J. M., Madison D. V. (2004). Discrete synaptic states define a major mechanism of synapse plasticity. Trends Neurosci. 27, 744–75010.1016/j.tins.2004.10.006
- Moran R. J., Symmonds M., Stephan K. E., Friston K. J., Dolan R. J. (2011). An in vivo assay of synaptic function mediating human cognition. Curr. Biol. 21, 1320–132510.1016/j.cub.2011.06.053
- Morgan H. L., Turner D. C., Corlett P. R., Absalom A. R., Adapa R., Arana F. S., et al. (2011). Exploring the impact of ketamine on the experience of illusory body ownership. Biol. Psychiatry 69, 35–4110.1016/j.biopsych.2010.07.032
- Morrison P. D. (2012). “5: the search for madness,” in Schizophrenia: The Final Frontier– A Festschrift for Robin M. Murray (Hove: Psychology Press; ), 71–85 Available at: [accessed January 10, 2013]
- Moutoussis M., Bentall R. P., El-Deredy W., Dayan P. (2011). Bayesian modelling of jumping-to-conclusions bias in delusional patients. Cogn. Neuropsychiatry 16, 422–44710.1080/13546805.2010.548678
- Mumford D. (1992). On the computational architecture of the neocortex. II. The role of cortico-cortical loops. Biol. Cybern. 66, 241–25110.1007/BF00198477
- Nordby H., Hammerborg D., Roth W. T., Hugdahl K. (1994). ERPs for infrequent omissions and inclusions of stimulus elements. Psychophysiology 31, 544–55210.1111/j.1469-8986.1994.tb02347.x
- O’Driscoll G. A., Callahan B. L. (2008). Smooth pursuit in schizophrenia: a meta-analytic review of research since 1993. Brain Cogn. 68, 359–37010.1016/j.bandc.2008.08.023
- Olney J. W., Farber N. B. (1995). Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry 52, 998–100710.1001/archpsyc.1995.03950240016004
- Opris I., Hampson R. E., Gerhardt G. A., Berger T. W., Deadwyler S. A. (2012). Columnar processing in primate pFC: evidence for executive control microcircuits. J. Cogn. Neurosci. 24, 2334–234710.1162/jocn_a_00307
- Oranje B., Gispen-de Wied C. C., Verbaten M. N., Kahn R. S. (2002). Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol. Biol. Psychiatry 52, 887–89510.1016/S0006-3223(02)01377-X
- Oranje B., Gispen-de Wied C. C., Westenberg H. G. M., Kemner C., Verbaten M. N., Kahn R. S. (2004). Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating. J. Psychopharmacol. (Oxford) 18, 388–39410.1177/026988110401800310
- O’Tuathaigh C. M. P., Salum C., Young A. M. J., Pickering A. D., Joseph M. H., Moran P. M. (2003). The effect of amphetamine on Kamin blocking and overshadowing. Behav. Pharmacol. 14, 315–32210.1097/01.fbp.0000080416.18561.3e
- Passafaro M., Piëch V., Sheng M. (2001). Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons. Nat. Neurosci. 4, 917–92610.1038/nn0901-917
- Passie T., Karst M., Borsutzky M., Wiese B., Emrich H. M., Schneider U. (2003). Effects of different subanaesthetic doses of (S)-ketamine on psychopathology and binocular depth inversion in man. J. Psychopharmacol. (Oxford) 17, 51–5610.1177/0269881103017001698
- Pellicano E., Burr D. (2012). When the world becomes “too real": a Bayesian explanation of autistic perception. Trends Cogn. Sci. (Regul. Ed.) 16, 504–51010.1016/j.tics.2012.08.009
- Perrone-Bizzozero N. I., Sower A. C., Bird E. D., Benowitz L. I., Ivins K. J., Neve R. L. (1996). Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 93, 14182–1418710.1073/pnas.93.24.14182
- Phillips W. A., Silverstein S. M. (2003). Convergence of biological and psychological perspectives on cognitive coordination in schizophrenia. Behav. Brain Sci. 26, 65–8210.1017/S0140525X03000025 discussion 82–137.
- Pierri J. N., Volk C. L., Auh S., Sampson A., Lewis D. A. (2001). Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch. Gen. Psychiatry 58, 466–47310.1001/archpsyc.58.5.466
- Radant A. D., Bowdle T. A., Cowley D. S., Kharasch E. D., Roy-Byrne P. P. (1998). Does ketamine-mediated N-methyl-D-aspartate receptor antagonism cause schizophrenia-like oculomotor abnormalities? Neuropsychopharmacology 19, 434–44410.1016/S0893-133X(98)00030-X
- Rajan I., Cline H. T. (1998). Glutamate receptor activity is required for normal development of tectal cell dendrites in vivo. J. Neurosci. 18, 7836–7846
- Rajkowska G., Selemon L. D., Goldman-Rakic P. S. (1998). Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry 55, 215–22410.1001/archpsyc.55.3.215
- Rao R. P., Ballard D. H. (1999). Predictive coding in the visual cortex: a functional interpretation of some extra-classical receptive-field effects. Nat. Neurosci. 2, 79–8710.1038/4580
- Razoux F., Garcia R., Léna I. (2007). Ketamine, at a dose that disrupts motor behavior and latent inhibition, enhances prefrontal cortex synaptic efficacy and glutamate release in the nucleus accumbens. Neuropsychopharmacology 32, 719–72710.1038/sj.npp.1301057
- Reilly J. L., Lencer R., Bishop J. R., Keedy S., Sweeney J. A. (2008). Pharmacological treatment effects on eye movement control. Brain Cogn. 68, 415–43510.1016/j.bandc.2008.08.026
- Reith J., Benkelfat C., Sherwin A., Yasuhara Y., Kuwabara H., Andermann F., et al. (1994). Elevated dopa decarboxylase activity in living brain of patients with psychosis. Proc. Natl. Acad. Sci. U.S.A. 91, 11651–1165410.1073/pnas.91.24.11651
- Richards A. M. (1968). Monaural loudness functions under masking. J. Acoust. Soc. Am. 44, 599–60510.1121/1.1911127
- Salinas E., Thier P. (2000). Gain modulation: a major computational principle of the central nervous system. Neuron 27, 15–2110.1016/S0896-6273(00)00004-0
- Schmidt A., Bachmann R., Kometer M., Csomor P. A., Stephan K. E., Seifritz E., et al. (2012). Mismatch negativity encoding of prediction errors predicts s-ketamine-induced cognitive impairments. Neuropsychopharmacology 37, 865–87510.1038/npp.2011.261
- Shergill S. S., Bays P. M., Frith C. D., Wolpert D. M. (2003). Two eyes for an eye: the neuroscience of force escalation. Science 301, 187.10.1126/science.1085327
- Shergill S. S., Samson G., Bays P. M., Frith C. D., Wolpert D. M. (2005). Evidence for sensory prediction deficits in schizophrenia. Am. J. Psychiatry 162, 2384–238610.1176/appi.ajp.162.12.2384
- Shi W.-X., Zhang X.-X. (2003). Dendritic glutamate-induced bursting in the prefrontal cortex: further characterization and effects of phencyclidine. J. Pharmacol. Exp. Ther. 305, 680–68710.1124/jpet.102.046359
- Silverstein S. M., Keane B. P. (2011). Perceptual organization impairment in schizophrenia and associated brain mechanisms: review of research from 2005 to 2010. Schizophr. Bull. 37, 690–69910.1093/schbul/sbr052
- Simpson E. H., Kellendonk C., Kandel E. (2010). A possible role for the striatum in the pathogenesis of the cognitive symptoms of schizophrenia. Neuron 65, 585–59610.1016/j.neuron.2010.02.014
- Speechley W. J., Whitman J. C., Woodward T. S. (2010). The contribution of hypersalience to the “jumping to conclusions” bias associated with delusions in schizophrenia. J. Psychiatry Neurosci. 35, 7–1710.1503/jpn.090025
- Stephan K. E., Baldeweg T., Friston K. J. (2006). Synaptic plasticity and dysconnection in schizophrenia. Biol. Psychiatry 59, 929–93910.1016/j.biopsych.2005.10.005
- Stephan K. E., Friston K. J., Frith C. D. (2009). Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr. Bull. 35, 509–52710.1093/schbul/sbn176
- Stone J. M., Erlandsson K., Arstad E., Squassante L., Teneggi V., Bressan R. A., et al. (2008). Relationship between ketamine-induced psychotic symptoms and NMDA receptor occupancy: a [(123)I]CNS-1261 SPET study. Psychopharmacology (Berl.) 197, 401–40810.1007/s00213-007-1047-x
- Sweeney J. A., Haas G. L., Li S., Weiden P. J. (1994). Selective effects of antipsychotic medications on eye-tracking performance in schizophrenia. Psychiatry Res. 54, 185–19810.1016/0165-1781(94)90006-X
- Sweet R. A., Bergen S. E., Sun Z., Marcsisin M. J., Sampson A. R., Lewis D. A. (2007). Anatomical evidence of impaired feedforward auditory processing in schizophrenia. Biol. Psychiatry 61, 854–86410.1016/j.biopsych.2006.07.033
- Teufel C., Kingdon A., Ingram J. N., Wolpert D. M., Fletcher P. C. (2010). Deficits in sensory prediction are related to delusional ideation in healthy individuals. Neuropsychologia 48, 4169–417210.1016/j.neuropsychologia.2010.10.024
- Thaker G. K., Ross D. E., Buchanan R. W., Adami H. M., Medoff D. R. (1999). Smooth pursuit eye movements to extra-retinal motion signals: deficits in patients with schizophrenia. Psychiatry Res. 88, 209–21910.1016/S0165-1781(99)00084-0
- Uhlhaas P. J., Millard I., Muetzelfeldt L., Curran H. V., Morgan C. J. A. (2007). Perceptual organization in ketamine users: preliminary evidence of deficits on night of drug use but not 3 days later. J. Psychopharmacol. (Oxford) 21, 347–35210.1177/0269881107077739
- Umbricht D., Schmid L., Koller R., Vollenweider F. X., Hell D., Javitt D. C. (2000). Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch. Gen. Psychiatry 57, 1139–114710.1001/archpsyc.57.12.1139
- Weiler M. A., Thaker G. K., Lahti A. C., Tamminga C. A. (2000). Ketamine effects on eye movements. Neuropsychopharmacology 23, 645–65310.1016/S0893-133X(00)00156-1
- Williams L. E., Ramachandran V. S., Hubbard E. M., Braff D. L., Light G. A. (2010). Superior size-weight illusion performance in patients with schizophrenia: evidence for deficits in forward models. Schizophr. Res. 121, 101–10610.1016/j.schres.2009.10.021
- Winterer G., McCarley R. W. (2011). “Electrophysiology of schizophrenia,” in Schizophrenia, eds Weinberger D. R., Harrison P. J. (Oxford: Wiley-Blackwell; ), 311–333
- World Health Organization (1992). ICD-10: International Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization
- Yabe H., Tervaniemi M., Reinikainen K., Näätänen R. (1997). Temporal window of integration revealed by MMN to sound omission. Neuroreport 8, 1971–197410.1097/00001756-199705260-00035
- Young A. M. J., Moran P. M., Joseph M. H. (2005). The role of dopamine in conditioning and latent inhibition: what, when, where and how? Neurosci. Biobehav. Rev. 29, 963–97610.1016/j.neubiorev.2005.02.004
Source: PubMed